Elevated Plasma Homocysteine Level in Vascular Dementia Reflects the Vascular Disease Process

被引:18
作者
Nilsson, Karin [1 ]
Gustafson, Lars [1 ]
Hultberg, Bjorn [2 ,3 ]
机构
[1] Lund Univ Hosp, Dept Psychogeriatr, Clin Sci, Lund, Sweden
[2] Lund Univ Hosp, Dept Lab Med, Div Clin Chem, Lund, Sweden
[3] Lund Univ Hosp, Inst Lab Med, Dept Clin Chem, SE-22185 Lund, Sweden
来源
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA | 2013年 / 3卷 / 01期
基金
英国医学研究理事会;
关键词
Cobalamin; Creatinine; Folate; Homocysteine; Depression; Vascular dementia; Vascular disease;
D O I
10.1159/000345981
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Patients with vascular dementia (VaD) exhibit particularly elevated levels of plasma total homocysteine (tHcy) compared to patients with other psychogeriatric diseases. Methods: We investigated the main determinants (age, renal impairment, cobalamin/folate status and presence of extracerebral vascular disease) of plasma tHcy in 525 patients with VaD. Furthermore, 270 patients with depression were used as a reference group to reveal the potential specificity of elevated plasma tHcy in patients with VaD. Results: Elevated plasma tHcy levels in patients with VaD could only partly be attributed to cobalamin/folate deficiency or renal impairment. Plasma tHcy might also be related to the vascular disease process since patients with depression and vascular disease exhibited similar plasma tHcy levels to patients with VaD. Conclusion: Our findings suggest that elevated plasma tHcy might be a sensitive marker for the vascular disease process in patients with VaD and that the level also is a reflection of changes in the other main determinants of plasma tHcy. Copyright (C) 2013 S. Karger AG, Basel
引用
收藏
页码:16 / 24
页数:9
相关论文
共 32 条
[1]  
American Psychiatric Association, 1994, DSM 4 DIAGN STAT MAN, V4
[2]  
ANDERSSON A, 1993, CLIN CHEM, V39, P1590
[3]   HOMOCYSTEINE AND CYSTEINE - DETERMINANTS OF PLASMA-LEVELS IN MIDDLE-AGED AND ELDERLY SUBJECTS [J].
BRATTSTROM, L ;
LINDGREN, A ;
ISRAELSSON, B ;
ANDERSSON, A ;
HULTBERG, B .
JOURNAL OF INTERNAL MEDICINE, 1994, 236 (06) :633-641
[4]   Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: An overview [J].
Castro, R ;
Rivera, I ;
Blom, HJ ;
Jakobs, C ;
de Almeida, IT .
JOURNAL OF INHERITED METABOLIC DISEASE, 2006, 29 (01) :3-20
[5]   Vitamin B12 and folate deficiency in later life [J].
Clarke, R ;
Evans, JG ;
Schneede, J ;
Nexo, E ;
Bates, C ;
Fletcher, A ;
Prentice, A ;
Johnston, C ;
Ueland, PM ;
Refsum, H ;
Sherliker, P ;
Birks, J ;
Whitlock, G ;
Breeze, E ;
Scott, JM .
AGE AND AGEING, 2004, 33 (01) :34-41
[6]   Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease [J].
Clarke, R ;
Smith, AD ;
Jobst, KA ;
Refsum, H ;
Sutton, L ;
Ueland, PM .
ARCHIVES OF NEUROLOGY, 1998, 55 (11) :1449-1455
[7]   Homocysteine and risk of ischemic heart disease and stroke -: A meta-analysis [J].
Clarke, R ;
Collins, R ;
Lewington, S ;
Donald, A ;
Alfthan, G ;
Tuomilehto, J ;
Arnesen, E ;
Bonaa, K ;
Blacher, J ;
Boers, GHJ ;
Bostom, A ;
Bots, ML ;
Grobee, DE ;
Brattström, L ;
Breteler, MMB ;
Hofman, A ;
Chambers, JC ;
Kooner, JS ;
Coull, BM ;
Evans, RW ;
Kuller, LH ;
Evers, S ;
Folsom, AR ;
Freyburger, G ;
Parrot, F ;
Genst, J ;
Dalery, K ;
Graham, IM ;
Daly, L ;
Hoogeveen, EK ;
Kostense, PJ ;
Stehouwer, CDA ;
Hopknis, PN ;
Jacques, P ;
Selhub, J ;
Luft, FC ;
Jungers, P ;
Lindgren, A ;
Lolin, YI ;
Loehrer, F ;
Fowler, B ;
Mansoor, MA ;
Malinow, MR ;
Ducimetiere, P ;
Nygard, O ;
Refsum, H ;
Vollset, SE ;
Ueland, PM ;
Omenn, GS ;
Beresford, SAA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (16) :2015-2022
[8]   One-Carbon Metabolism and Alzheimer's Disease: Focus on Epigenetics [J].
Coppede, Fabio .
CURRENT GENOMICS, 2010, 11 (04) :246-260
[9]  
Fratiglioni L, 2000, NEUROLOGY, V54, pS10
[10]   Neurovascular dysfunction, inflammation and endothelial activation: Implications for the pathogenesis of Alzheimer's disease [J].
Grammas, Paula .
JOURNAL OF NEUROINFLAMMATION, 2011, 8